#USA #Smithfield #ALCOR Scientific #iSED #VSG Test

Extending the Limit: A Revolutionary Change in VSG Testing

A recent peer-reviewed study has unveiled a significant advancement in laboratory technology, highlighting that the traditional four-hour limit for Erythrocyte Sedimentation Rate (ESR) tests is no longer a constraint. Conducted by ALCOR Scientific, the study focuses on their innovative iSED® analyzers that promise to transform laboratory logistics and patient management.

The Limitations of Traditional Testing

For decades, the ESR test, a critical tool in diagnosing infections and autoimmune diseases, was governed by the strict four-hour timeframe within which samples needed to be processed. Beyond this period, results could become unreliable due to changes in sample integrity. This posed challenges for clinical laboratories dealing with delayed transport times or staff shortages, often compromising the accuracy of patient results.

Breakthrough Findings

The study, published in the journal Diagnostics, reveals that samples analyzed using ALCOR's iSED® technology maintained their precision for up to 28 hours at room temperature and 48 hours when refrigerated. This represents a staggering sevenfold increase over the previous four-hour limit imposed by the traditional Westergren method. Such stability in sample analysis not only augments the logistics of laboratory processes but also improves the overall patient experience.

Enhancing Patient Care

With extended sample stability, clinical laboratories can now confidently analyze samples that arrive late or outside regular hours. This shift significantly reduces the need for repeat blood draws, which are often costly and uncomfortable for patients. Furthermore, laboratories can now process samples for both ESR and complete blood count tests from the same tube, optimizing workflow and reducing waste.

Addressing Laboratory Challenges

The modern landscape of laboratory work often involves navigating complex logistics due to dispersed blood draw sites and lengthening transportation routes. With the introduction of iSED® analyzers, ALCOR aims to alleviate these burdened processes. The technology employs photometric rheology, which measures the earliest stages of red blood cell aggregation in a controlled environment, minimizing the influence of external factors like time and temperature on results.

Jim Post, CEO of ALCOR Scientific, emphasizes that this technological advancement is not just an operational convenience; it fundamentally enhances medical practices by ensuring reliable results crucial for diagnosis and treatment.

Conclusion

The iSED® analyzer's leap from a four-hour stabilization to a remarkable 28 hours signifies a monumental shift in laboratory medicine, promising improvements in efficiency, patient care, and overall healthcare delivery. This groundbreaking change marks a new chapter for laboratories, as they adapt to the demands of modern medical practice while ensuring the highest standards of patient care.

For those interested in exploring the details of this study, it is accessible at MDPI.

About ALCOR Scientific

Founded in 2011, ALCOR Scientific focuses on developing innovative diagnostic technologies to enhance laboratory efficiency. With an understanding of life sciences and advanced manufacturing techniques, the company is committed to providing healthcare professionals with time-saving solutions that improve patient management.